학술논문
Population Pharmacokinetics of MYL-1402O, a Proposed Biosimilar to Bevacizumab and Reference Product (Avastin® ) in Patients with Non-squamous Non-small Cell Lung Cancer
Document Type
Article
Author
Source
In: European Journal of Drug Metabolism and Pharmacokinetics . (European Journal of Drug Metabolism and Pharmacokinetics, November 2023, 48(6):675-689)
Subject
Language
English
ISSN
21070180
03787966
03787966